Betaine Attenuates Hyperhomocysteinemia-Induced Cognitive Impairment by Suppressing Oxidative Stress and Activating the PI3K/AKT/GSK-3β Pathway
Antioxidants · 27.06.2026 · 15 (7) · 807
DOI: 10.3390/antiox15070807 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antioxidants, online erschienen am 27.06.2026. Verfasst von Xiaolong Gu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Shanxi Key Laboratory of Birth Defect and Cell Regeneration, Department of Biochemistry and Molecular Biology, Shanxi Medical University, Taiyuan 030…. Die Arbeit nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Shanxi Basic Research Program, Science Research Start⁃up Fund for Doctor of Shanxi Medical University.
Abstract (Originalsprache)
High homocysteine levels are a key risk factor for cognitive impairment, a major public health concern in aging societies. Although betaine is known to reduce Hcy levels, its effects on hyperhomocysteinemia (hHcy)-induced cognitive impairment and the underlying mechanisms remain unclear. Here, we established an hHcy-induced cognitive impairment mouse model by feeding mice a high-methionine diet for 8 weeks, followed by betaine supplementation for 14 days. Betaine treatment attenuated hHcy-induced cognitive impairment. This improvement was accompanied by alleviation of neuropathological alterations and enhancement of antioxidant capacity. Notably, betaine suppressed reactive oxygen species (ROS) accumulation, neuronal apoptosis, and Tau hyperphosphorylation at Ser396 and Thr231 in both mouse hippocampus and HT-22 cells. Mechanistically, betaine-induced activation of the PI3K/AKT/GSK-3β pathway was effectively blocked by the PI3K inhibitor LY294002. Notably, treatment with the ROS scavenger N-acetylcysteine (NAC) alone phenocopied this activation, suggesting that ROS functions as an upstream regulator of this signaling cascade. Collectively, our data demonstrate that betaine attenuates hHcy-induced cognitive impairment by suppressing oxidative stress-driven apoptosis and Tau pathology through modulation of the PI3K/AKT/GSK-3β signaling pathway. These findings suggest that betaine may hold promise for further preclinical and clinical studies, although long-term efficacy and safety evaluations remain necessary.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Shanxi Key Laboratory of Birth Defect and Cell Regeneration, Department of Biochemistry and Molecular Biology, Shanxi Medical University, Taiyuan 030001, China.
- Key Laboratory of Coal Environmental Pathogenicity and Prevention, Ministry of Education, Shanxi Medical University, Taiyuan 030001, China.
- School of Pharmaceutical Science, Shanxi Medical University, Taiyuan 030001, China.
ORCID-Profile: Xiaolong Gu, Yuan Fu, Qi Xie, Jun Xie
Förderung
- National Natural Science Foundation of China
- Shanxi Basic Research Program
- Science Research Start⁃up Fund for Doctor of Shanxi Medical University
- Shanxi Province Higher Education "Billion Project" Science and Technology Guidance Project
- Shanxi Province Higher Education “Billion Project” Science and Technology Guidance Project
Zitieren
APA
Gu, X., Fu, Y., Zhao, Y., Liu, Z., Yang, Y., Xie, Q., Ma, P., Peng, Z., Liu, Z., Li, J., & Xie, J. (2026). Betaine Attenuates Hyperhomocysteinemia-Induced Cognitive Impairment by Suppressing Oxidative Stress and Activating the PI3K/AKT/GSK-3β Pathway. Antioxidants, 15(7), 807. https://doi.org/10.3390/antiox15070807
Vancouver
Gu X, Fu Y, Zhao Y, Liu Z, Yang Y, Xie Q, et al. Betaine Attenuates Hyperhomocysteinemia-Induced Cognitive Impairment by Suppressing Oxidative Stress and Activating the PI3K/AKT/GSK-3β Pathway. Antioxidants. 2026;15(7):807. doi:10.3390/antiox15070807
BibTeX
@article{Gu2026,
author = {Gu, Xiaolong and Fu, Yuan and Zhao, Yongli and Liu, Zhenyi and Yang, Yixiao and Xie, Qi and Ma, Peng and Peng, Zhiwei and Liu, Zhizhen and Li, Jianting and Xie, Jun},
title = {Betaine Attenuates Hyperhomocysteinemia-Induced Cognitive Impairment by Suppressing Oxidative Stress and Activating the PI3K/AKT/GSK-3β Pathway},
journal = {Antioxidants},
year = {2026},
volume = {15},
number = {7},
pages = {807},
doi = {10.3390/antiox15070807}
}
EUVIMED